Mobile

Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP/FF), as reliever, upon exhaled nitric oxide in asthma. FENOMENO study (Fractional Exhaled Nitric Oxide-Multiple Expi...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-004377-26

Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP/FF), as reliever, upon exhaled nitric oxide in asthma. FENOMENO study (Fractional Exhaled Nitric Oxide-Multiple Expiration flow of NO). A single-centre, placebo controlled, randomized, double blind, cross-over study

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate in asthmatic patients treated with CHF1535 maintenance therapy the effects of inhaled CHF1535 or salbutamol as reliever medications on airway inflammation as reflected by fractional exhaled NO (FENO) measured after a 28-days treatment period.

Critère d'inclusion

  • Moderate asthma

Liens